Pancreatic Cancer News & Features
Metastatic capabilities of pancreatic cancer might arise before tumors even form. Metastasis and advanced stage of disease at diagnosis are attributed to low survival rates for pancreatic cancer.
Combining a laboratory ultrasound technique called sonoporation with the commercially available chemotherapy compound gemcitabine increases the porosity of pancreatic cells with microbubbles and helps get the drug into cancer cells.
Despite the increased risk, patients whose pancreatic cancer tumor has grown to encompass critical blood vessels can be candidates for surgery. Data on efforts to fine-tune a protocol for these patients were presented at the SSAT 57th Annual Meeting.
Adjuvant gemcitabine plus capecitabine significantly improved overall survival compared with gemcitabine monotherapy in patients with pancreatic ductal adenocarcinoma, according to results of the ESPAC-4 trial presented at the ASCO 2016 Annual Meeting.
Chemoradiotherapy Showed No Survival Benefit Over Chemotherapy in Locally Advanced Pancreatic Cancer
Researchers discovered no survival benefit of chemoradiotherapy over chemotherapy in treating locally advanced pancreatic cancer in the LAP01 Randomized Clinical Trial.
- Baseline PSA Levels in Midlife Could Predict Risk of Lethal Prostate Cancer
- Imaging Technique Is Predictive of Immunotherapy Response in Non-Small Cell Lung Cancer
- Preoperative Breast MRI Affected by Patient Positioning
- Overall Survival and Progression-Free Survival Are Improved With Ibrutinib for del17p CLL
- Blinatumomab Improves Overall Survival in Acute Lymphoblastic Leukemia
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Triple-Drug Therapy Produces Response in Triple-Negative Breast Cancer, Mouse Study Shows
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Study Supports Increased Role for Surgery in Multimodality Therapy for Early Stage SCLC
- Autologous Stem Cell Transplant Safe as Standard of Care in Patients With HIV-Associated Lymphoma
- Surgery Improves Quality of Life for Patients With Malignant Pleural Mesothelioma
- Markers Found on Solid Tumors Are a Target for CAR T Cell Therapy
- Treating Patients With Cancer and Mental Health Disorders
- Type of End-of-Life Care Received Varies Based on Type of Disease
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|